These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 17162204)
1. Pantothenate-kinase associated neurodegeneration (PKAN) "eye of the tiger" sign. Renaud DL; Kotagal S Pediatr Neurol; 2007 Jan; 36(1):70-1. PubMed ID: 17162204 [No Abstract] [Full Text] [Related]
2. Genetic heterogeneity in patients with pantothenate kinase-associated neurodegeneration and classic magnetic resonance imaging eye-of-the-tiger pattern. Valentino P; Annesi G; Cirò Candiano IC; Annesi F; Civitelli D; Tarantino P; Naso F; Spadafora P; Carrideo S; De Marco EV; Consoli D; Zappia M; Gambardella A; Quattrone A Mov Disord; 2006 Feb; 21(2):252-4. PubMed ID: 16149094 [TBL] [Abstract][Full Text] [Related]
3. Missense PANK2 mutation without "eye of the tiger" sign: MR findings in a large group of patients with pantothenate kinase-associated neurodegeneration (PKAN). Delgado RF; Sanchez PR; Speckter H; Then EP; Jimenez R; Oviedo J; Dellani PR; Foerster B; Stoeter P J Magn Reson Imaging; 2012 Apr; 35(4):788-94. PubMed ID: 22127788 [TBL] [Abstract][Full Text] [Related]
4. Pantothenate kinase-associated neurodegeneration (PKAN): molecular confirmation of a Turkish patient with a rare frameshift mutation in the coding region of the PANK2 gene. Cangül H; Ozdemir O; Yakut T; Okan M; Morgan NV; Baytan B; Kurian MA; Spiegel R; Maher ER Turk J Pediatr; 2009; 51(2):161-5. PubMed ID: 19480328 [TBL] [Abstract][Full Text] [Related]
5. The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome. Baumeister FA; Auer DP; Hörtnagel K; Freisinger P; Meitinger T Neuropediatrics; 2005 Jun; 36(3):221-2. PubMed ID: 15944911 [TBL] [Abstract][Full Text] [Related]
6. First cases in the Czech Republic of the Hallervorden-Spatz disease resulting from mutation in the pantothenate kinase 2 gene. Zumrová A; Krepelová A; Kyncl M; Maríková T; Prosková M; Cíbochová R; Sebronová V; Komárek V Neuro Endocrinol Lett; 2005 Jun; 26(3):213-8. PubMed ID: 15990724 [TBL] [Abstract][Full Text] [Related]
7. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration. Thomas M; Hayflick SJ; Jankovic J Mov Disord; 2004 Jan; 19(1):36-42. PubMed ID: 14743358 [TBL] [Abstract][Full Text] [Related]
13. Mineral deposition on magnetic resonance imaging in chorea-acanthocytosis: a pathogenic link with pantothenate kinase-associated neurodegeneration? Kaul B; Goyal V; Shukla G; Srivastava A; Garg A; Bader B; Danek A; Hayflick S; Behari M Neurol India; 2013; 61(2):169-70. PubMed ID: 23644319 [No Abstract] [Full Text] [Related]
14. A novel gene mutation in PANK2 in a patient with an atypical form of pantothenate kinase-associated neurodegeneration. Pérez-González EA; Chacón-Camacho OF; Arteaga-Vázquez J; Zenteno JC; Mutchinick OM Eur J Med Genet; 2013 Nov; 56(11):606-8. PubMed ID: 24075960 [TBL] [Abstract][Full Text] [Related]
15. A novel PANK2 gene mutation in a Persian boy: the first report from Iran. Aryani O; Houshmand M; Fatehi F Clin Neurol Neurosurg; 2013 Jul; 115(7):1170-2. PubMed ID: 23116688 [No Abstract] [Full Text] [Related]